| Authors: |
Acosta JC; Cell Proliferation Group, MRC Clinical Sciences Centre, Imperial College London, Hammersmith Campus, London, UK.; Epigenetics Section, MRC Clinical Sciences Centre, Imperial College London, Hammersmith Campus, London, UK.; Edinburgh Cancer Research UK Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Edinburgh, UK., Banito A; Cell Proliferation Group, MRC Clinical Sciences Centre, Imperial College London, Hammersmith Campus, London, UK.; Epigenetics Section, MRC Clinical Sciences Centre, Imperial College London, Hammersmith Campus, London, UK., Wuestefeld T; Division of Translational Gastrointestinal Oncology, Department of Internal Medicine I, Eberhard Karls University Tübingen, Tübingen, Germany., Georgilis A; Cell Proliferation Group, MRC Clinical Sciences Centre, Imperial College London, Hammersmith Campus, London, UK.; Epigenetics Section, MRC Clinical Sciences Centre, Imperial College London, Hammersmith Campus, London, UK., Janich P; Center for Genomic Regulation and UPF, Barcelona, Spain., Morton JP; The Beatson Institute for Cancer Research, Glasgow, UK., Athineos D; The Beatson Institute for Cancer Research, Glasgow, UK., Kang TW; Division of Translational Gastrointestinal Oncology, Department of Internal Medicine I, Eberhard Karls University Tübingen, Tübingen, Germany., Lasitschka F; Institute of Pathology, University of Heidelberg, and Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Andrulis M; Institute of Pathology, University of Heidelberg, and Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Pascual G; Center for Genomic Regulation and UPF, Barcelona, Spain., Morris KJ; Cell Proliferation Group, MRC Clinical Sciences Centre, Imperial College London, Hammersmith Campus, London, UK.; Epigenetics Section, MRC Clinical Sciences Centre, Imperial College London, Hammersmith Campus, London, UK., Khan S; Cell Proliferation Group, MRC Clinical Sciences Centre, Imperial College London, Hammersmith Campus, London, UK.; Epigenetics Section, MRC Clinical Sciences Centre, Imperial College London, Hammersmith Campus, London, UK., Jin H; Department of Biochemistry, University of Leicester, Leicester, UK., Dharmalingam G; Epigenetics Section, MRC Clinical Sciences Centre, Imperial College London, Hammersmith Campus, London, UK., Snijders AP; Proteomics Facility, MRC Clinical Sciences Centre, Imperial College London, Hammersmith Campus, London, UK., Carroll T; Epigenetics Section, MRC Clinical Sciences Centre, Imperial College London, Hammersmith Campus, London, UK., Capper D; Institute of Pathology, University of Heidelberg, and Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Neuropathology, University of Heidelberg, and Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Pritchard C; Department of Biochemistry, University of Leicester, Leicester, UK., Inman GJ; Medical Research Institute, University of Dundee, Dundee, UK., Longerich T; Institute of Pathology, University of Heidelberg, and Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Sansom OJ; The Beatson Institute for Cancer Research, Glasgow, UK., Benitah SA; Center for Genomic Regulation and UPF, Barcelona, Spain., Zender L; Division of Translational Gastrointestinal Oncology, Department of Internal Medicine I, Eberhard Karls University Tübingen, Tübingen, Germany., Gil J; Cell Proliferation Group, MRC Clinical Sciences Centre, Imperial College London, Hammersmith Campus, London, UK. jesus.gil@csc.mrc.ac.uk.; Epigenetics Section, MRC Clinical Sciences Centre, Imperial College London, Hammersmith Campus, London, UK. jesus.gil@csc.mrc.ac.uk. |
